1. Home
  2. SGMO vs AILE Comparison

SGMO vs AILE Comparison

Compare SGMO & AILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMO
  • AILE
  • Stock Information
  • Founded
  • SGMO 1995
  • AILE 2010
  • Country
  • SGMO United States
  • AILE United States
  • Employees
  • SGMO N/A
  • AILE N/A
  • Industry
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • AILE Blank Checks
  • Sector
  • SGMO Health Care
  • AILE Finance
  • Exchange
  • SGMO Nasdaq
  • AILE Nasdaq
  • Market Cap
  • SGMO 180.5M
  • AILE 184.9M
  • IPO Year
  • SGMO 2000
  • AILE N/A
  • Fundamental
  • Price
  • SGMO $2.51
  • AILE $0.87
  • Analyst Decision
  • SGMO Buy
  • AILE Strong Buy
  • Analyst Count
  • SGMO 3
  • AILE 1
  • Target Price
  • SGMO $7.00
  • AILE $18.00
  • AVG Volume (30 Days)
  • SGMO 7.3M
  • AILE 453.5K
  • Earning Date
  • SGMO 11-12-2024
  • AILE 02-15-2025
  • Dividend Yield
  • SGMO N/A
  • AILE N/A
  • EPS Growth
  • SGMO N/A
  • AILE N/A
  • EPS
  • SGMO N/A
  • AILE N/A
  • Revenue
  • SGMO $52,291,000.00
  • AILE $485,830,000.00
  • Revenue This Year
  • SGMO N/A
  • AILE $30.99
  • Revenue Next Year
  • SGMO $11.46
  • AILE $24.92
  • P/E Ratio
  • SGMO N/A
  • AILE N/A
  • Revenue Growth
  • SGMO N/A
  • AILE 36.04
  • 52 Week Low
  • SGMO $0.30
  • AILE $0.70
  • 52 Week High
  • SGMO $3.18
  • AILE $20.00
  • Technical
  • Relative Strength Index (RSI)
  • SGMO 55.54
  • AILE 34.36
  • Support Level
  • SGMO $2.24
  • AILE $0.94
  • Resistance Level
  • SGMO $2.82
  • AILE $1.16
  • Average True Range (ATR)
  • SGMO 0.28
  • AILE 0.11
  • MACD
  • SGMO 0.02
  • AILE -0.02
  • Stochastic Oscillator
  • SGMO 52.88
  • AILE 18.71

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About AILE iLearningEngines Inc. Common Stock

iLearningEngines Inc is an AI and automation platform that empowers its customers to productize their institutional knowledge by transforming it into actionable intellectual property that enhances outcomes for employees, customers and other stakeholders. Its platform enables enterprises to build intelligent Knowledge Clouds that incorporate large volumes of structured and unstructured information across disparate internal and external systems and to automate organizational processes that leverage these Knowledge Clouds to improve performance. The company combines its offerings with vertically focused capabilities and data models to operationalize AI and automation to effectively and efficiently address critical challenges facing its customers.

Share on Social Networks: